In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Antibiotic resistance is a growing global health concern.
• Evaluating the in vitro efficacy of broad-spectrum antibiotics is crucial for guiding treatment strategies.

Purpose of the Study:

• To assess the in vitro antibacterial activity of ciprofloxacin against a diverse range of hospital bacterial isolates.
• To compare ciprofloxacin's efficacy with other commonly used antibiotics.

Main Methods:

• In vitro susceptibility testing of 385 hospital bacterial isolates from three distinct geographical regions.
• Determination of minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs).
• Evaluation of ciprofloxacin's activity under varying conditions (inoculum size, serum presence, anaerobic environment, pH).

Main Results:

• Ciprofloxacin exhibited potent in vitro activity against most tested strains, with only 3 out of 385 isolates showing resistance.
• It demonstrated superior or comparable activity against Gram-negative and Gram-positive bacteria when compared to gentamicin, mezlocillin, cefotaxime, azlocillin, cefsulodin, cloxacillin, and cefamandole.
• Activity was consistent in broth and agar, with MICs similar to MBCs, and minimal impact from inoculum size, serum, or anaerobic conditions. However, decreased pH significantly increased MICs.
• Ciprofloxacin showed rapid bactericidal effects and a minimal post-antibiotic effect.

Conclusions:

• Ciprofloxacin possesses favorable in vitro characteristics, including broad-spectrum activity and rapid bactericidal action.
• Its consistent performance across various conditions suggests potential clinical utility.
• Further clinical studies are warranted to confirm these promising in vitro findings.